To the Editor: Serotonin toxicity is an under-recognised, potentially fatal syndrome that is becoming more common as the use of serotonergic drugs increases.1 We report a case of serotonin toxicity following the concomitant use of the antidepressant citalopram and methylene blue.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- Southmead Hospital, Bristol, United Kingdom.
Correspondence: john.whitaker@trinity-oxford.com
- 1. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med 2005; 352: 1112-1120.
- 2. Ramsay RR, Dunford C, Gillman PK. Methylene blue and serotonin toxicity: inhibition of monoamine oxidase A (MAO A) confirms a theoretical prediction. Br J Pharmacol 2007; 152: 946-951.
- 3. Kartha SS, Chacko CE, Bumpous JM, et al. Toxic metabolic encephaolopathy after parathyroidectomy with methylene blue localization. Otolaryngol Head Neck Surg 2006; 135: 765-768.
Online responses are no longer available. Please refer to our instructions for authors page for more information.